Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

Glipizide - Generic Drug Details

« Back to Dashboard

What are the generic sources for glipizide and what is the scope of glipizide freedom to operate?

Glipizide
is the generic ingredient in five branded drugs marketed by Sandoz, Barr Labs Inc, Unique Pharm Labs, Sun Pharm Inds Inc, Watson Labs, Mylan, Pfizer, Accord Hlthcare, Par Pharm, Vintage Pharms Llc, Ani Pharms Inc, Apotex, Mylan Pharms Inc, Zydus Pharms Usa Inc, Corepharma, Heritage Pharms Inc, Bristol Myers Squibb, and Teva Pharms, and is included in twenty-six NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Glipizide has twenty-three patent family members in nineteen countries.

There are eighteen drug master file entries for glipizide. Fifty-six suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: glipizide

Tradenames:5
Patents:2
Applicants:18
NDAs:26
Drug Master File Entries: see list18
Suppliers / Packagers: see list56
Bulk Api Vendors: see list72
Clinical Trials: see list14
Patent Applications: see list5,666
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:glipizide at DailyMed

Pharmacology for Ingredient: glipizide

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea

Tentative approvals for GLIPIZIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe2.5MGTABLET, EXTENDED RELEASE;ORAL
► Subscribe► Subscribe10MGTABLET, EXTENDED RELEASE;ORAL
► Subscribe► Subscribe5MGTABLET, EXTENDED RELEASE;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
GLIPIZIDE AND METFORMIN HYDROCHLORIDE
glipizide; metformin hydrochloride
TABLET;ORAL078083-001Apr 12, 2007ABRXNoNo► Subscribe► Subscribe
Mylan
GLIPIZIDE
glipizide
TABLET;ORAL074226-001May 10, 1994ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Inc
GLIPIZIDE
glipizide
TABLET;ORAL077820-002Jul 11, 2006ABRXNoNo► Subscribe► Subscribe
Unique Pharm Labs
GLIPIZIDE
glipizide
TABLET, EXTENDED RELEASE;ORAL204720-001Dec 29, 2016ABRXNoNo► Subscribe► Subscribe
Pfizer
GLUCOTROL XL
glipizide
TABLET, EXTENDED RELEASE;ORAL020329-003Aug 10, 1999ABRXYesNoRE44459► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot